Bristol-Myers Squibb
BMY
#192
Rank
A$170.19 B
Marketcap
A$83.35
Share price
3.85%
Change (1 day)
18.26%
Change (1 year)

Bristol-Myers Squibb (BMY) - P/B ratio

P/B ratio as of June 2026 : 5.78

According to Bristol-Myers Squibb's latest financial reports the company has a price-to-book ratio of 2.39785.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Bristol-Myers Squibb - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-315.88-17.62%
2024-12-317.14101.6%
2023-12-313.54-27.97%
2022-12-314.9227.9%
2021-12-313.843.88%
2020-12-313.7033.76%
2019-12-312.77-53.7%
2018-12-315.98-29.42%
2017-12-318.4741.7%
2016-12-315.97-24.58%
2015-12-317.9221.64%
2014-12-316.5113.76%
2013-12-315.7246.97%
2012-12-313.903.5%
2011-12-313.7630.82%
2010-12-312.88-1.43%
2009-12-312.92-22.59%
2008-12-313.77-23.94%
2007-12-314.96-4.1%
2006-12-315.1728.81%
2005-12-314.01-17.94%
2004-12-314.89-13.76%
2003-12-315.679.77%
2002-12-315.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.52 29.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.61 31.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.52-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-65.9-1,238.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
34.5 496.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
20.9 261.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.20-79.20%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
1.69-70.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6.86 18.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6.18 6.92%๐Ÿ‡ฌ๐Ÿ‡ง UK